On Monday, Sarepta Therapeutics Inc (NASDAQ: SRPT) opened lower -3.71% from the last session, before settling in for the closing price of $122.87. Price fluctuations for SRPT have ranged from $55.25 to $159.89 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 32.89%. Company’s average yearly earnings per share was noted 140.51% at the time writing. With a float of $88.26 million, this company’s outstanding shares have now reached $93.73 million.
Let’s determine the extent of company efficiency that accounts for 1314 employees.
Sarepta Therapeutics Inc (SRPT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Sarepta Therapeutics Inc is 5.96%, while institutional ownership is 86.80%. The most recent insider transaction that took place on Mar 11 ’24, was worth 93,550. In this transaction Director of this company sold 761 shares at a rate of $122.93, taking the stock ownership to the 7,516 shares. Before that another transaction happened on Mar 08 ’24, when Company’s Director sold 15,000 for $123.25, making the entire transaction worth $1,848,795. This insider now owns 22,840 shares in total.
Sarepta Therapeutics Inc (SRPT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 118.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 140.51% per share during the next fiscal year.
Sarepta Therapeutics Inc (NASDAQ: SRPT) Trading Performance Indicators
Check out the current performance indicators for Sarepta Therapeutics Inc (SRPT). In the past quarter, the stock posted a quick ratio of 3.45. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.16, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach 11.01 in one year’s time.
Technical Analysis of Sarepta Therapeutics Inc (SRPT)
Looking closely at Sarepta Therapeutics Inc (NASDAQ: SRPT), its last 5-days average volume was 0.59 million, which is a drop from its year-to-date volume of 1.01 million. As of the previous 9 days, the stock’s Stochastic %D was 13.78%. Additionally, its Average True Range was 3.55.
During the past 100 days, Sarepta Therapeutics Inc’s (SRPT) raw stochastic average was set at 61.62%, which indicates a significant increase from 3.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 18.55% in the past 14 days, which was lower than the 41.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $126.97, while its 200-day Moving Average is $111.21. However, in the short run, Sarepta Therapeutics Inc’s stock first resistance to watch stands at $121.60. Second resistance stands at $124.90. The third major resistance level sits at $126.81. If the price goes on to break the first support level at $116.40, it is likely to go to the next support level at $114.49. Should the price break the second support level, the third support level stands at $111.19.
Sarepta Therapeutics Inc (NASDAQ: SRPT) Key Stats
There are currently 93,900K shares outstanding in the company with a market cap of 11.10 billion. Presently, the company’s annual sales total 1,243 M according to its annual income of -535,980 K. Last quarter, the company’s sales amounted to 396,780 K and its income totaled 45,650 K.
